| | | | | |
| | | Panel splinters on what to do about Avandia Fri, 07 Jun, 2013 12:46 AM PDT A splintered panel of advisers to the U.S. Food and Drug Administration recommended Thursday that the agency modify an extra warning on the type 2 diabetes drug Avandia, made by pharmaceutical giant GlaxoSmithKline. Continue reading | |
| | | FDA panel wants changes to diabetes pill Thu, 06 Jun, 2013 11:36 PM PDT WASHINGTON -- Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not in… Continue reading | |
FDA panel favors easing safety limits on Avandia Thu, 06 Jun, 2013 10:04 PM PDT Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as much as... Continue reading | | FDA panel wants changes to Avandia safety measures Thu, 06 Jun, 2013 09:37 PM PDT An independent advisory panel convened by the Food and Drug Administration has recommended loosening prescribing restrictions on Avandia, GlaxoSmithKline PLC's diabetes drug, citing new data that suggest the heart attack risks associated with it are "modest." Continue reading | | |
| |
No comments:
Post a Comment